logo

Freeline Therapeutics Holdings Plc (FRLN)



Trade FRLN now with
  Date
  Headline
9/9/2021 7:36:37 AM Freeline Announces Orphan Drug Designations For FLT201 For Gaucher Disease
6/16/2021 7:10:56 AM Freeline Doses Second Patient In Phase 1/2 MARVEL-1 Clinical Trial For Fabry Disease
3/11/2021 7:17:04 AM Freeline Appoints Colin Love To Board
9/28/2020 7:12:44 AM Freeline Therapeutics Announces Promotion Of Romuald Corbau To Chief Scientific Officer
9/23/2020 7:11:38 AM Freeline Therapeutics Announces Supply Agreement With Thermo Fisher Scientific